Zobrazeno 1 - 10
of 182
pro vyhledávání: '"E. Burd"'
Autor:
Geoffrey Fell, Ashley E. Rosko, Gregory A. Abel, Clark Dumontier, Kelly J. Higby, Anays Murillo, Donna S. Neuberg, Christin E. Burd, Andrew A. Lane
Publikováno v:
British Journal of Haematology. 199:100-105
Autor:
Gang Wang, Jianlong Li, Linda Bojmar, Haiyan Chen, Zhong Li, Gabriel C. Tobias, Mengying Hu, Edwin A. Homan, Serena Lucotti, Fengbo Zhao, Valentina Posada, Peter R. Oxley, Michele Cioffi, Han Sang Kim, Huajuan Wang, Pernille Lauritzen, Nancy Boudreau, Zhanjun Shi, Christin E. Burd, Jonathan H. Zippin, James C. Lo, Geoffrey S. Pitt, Jonathan Hernandez, Constantinos P. Zambirinis, Michael A. Hollingsworth, Paul M. Grandgenett, Maneesh Jain, Surinder K. Batra, Dominick J. DiMaio, Jean L. Grem, Kelsey A. Klute, Tanya M. Trippett, Mikala Egeblad, Doru Paul, Jacqueline Bromberg, David Kelsen, Vinagolu K. Rajasekhar, John H. Healey, Irina R. Matei, William R. Jarnagin, Robert E. Schwartz, Haiying Zhang, David Lyden
Publikováno v:
Nature.
Autor:
Keiran S.M. Smalley, Paulo C. Rodriguez, Yian A. Chen, Christin E. Burd, Uwe Rix, Kenneth Y. Tsai, Kimberly T. Nguyen, Zeynep Eroglu, Dennis O. Adeegbe, David Noyes, Peter A. Forsyth, Brian J. Czerniecki, Vinayak Palve, Derek R. Duckett, Inna Smalley, Michael A. Davies, Eslam Mohamed, Jiannong Li, Zhihua Chen, Manali S. Phadke
Immunotherapy (IT) and targeted therapy (TT) are both effective against melanoma, but their combination is frequently toxic. Here, we investigated whether the sequence of IT (anti–PD-1)→ TT (ceritinib–trametinib or dabrafenib–trametinib) was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50b9bb63fd2da0db237760d414a79777
https://doi.org/10.1158/2326-6066.c.6550279
https://doi.org/10.1158/2326-6066.c.6550279
Autor:
Keiran S.M. Smalley, Paulo C. Rodriguez, Yian A. Chen, Christin E. Burd, Uwe Rix, Kenneth Y. Tsai, Kimberly T. Nguyen, Zeynep Eroglu, Dennis O. Adeegbe, David Noyes, Peter A. Forsyth, Brian J. Czerniecki, Vinayak Palve, Derek R. Duckett, Inna Smalley, Michael A. Davies, Eslam Mohamed, Jiannong Li, Zhihua Chen, Manali S. Phadke
S1: IT monotherapy in SW1 model S2: IT->dabrafenib-trametinib therapy in BRAF mutant melanoma. S3: IT->TT sequence in NRAS#5 model S4: Expanded heatmap of all immune cells S5: IT->TT increases accumulation of activated CD8+ T cells S6: The TT->IT seq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00d2accefee1e50cca9f7a873ce9b54a
https://doi.org/10.1158/2326-6066.22543471
https://doi.org/10.1158/2326-6066.22543471
Autor:
Norman E. Sharpless, Sharon L. Campbell, Bruce C. Baguley, Michael J. Miley, Daniel C. Zedek, David B. Darr, George P. Souroullas, William R. Jeck, Brit L. Martin, Kailing Fu, Kelly S. Clark, James E. Gillahan, Meriam A. Waqas, Minh V. Huynh, Wenjin Liu, Christin E. Burd
Figure S1. Generation of the LSL-N-RasQ61R allele. Figure S2. Conditional expression of N-Ras mutants does not alter melanocyte morphology. Figure S3. In both the heterozygous and homozygous state, NRasG12D fails to induce melanoma formation. Figure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a5c3e3adfbf56270fa607f7d8df27f8
https://doi.org/10.1158/2159-8290.22530242.v1
https://doi.org/10.1158/2159-8290.22530242.v1
Autor:
Christin E. Burd, Jianying Zhang, Reena Shakya, Christina Y. Yu, Rebecca C. Hennessey, Kyle M. LaPak, Xiangnan Guan
Real-time PCR hit validation.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c3a95c89975fb1160563ffe2b7cf3d
https://doi.org/10.1158/1541-7786.22511602
https://doi.org/10.1158/1541-7786.22511602
Autor:
Christin E. Burd, Jianying Zhang, Reena Shakya, Christina Y. Yu, Rebecca C. Hennessey, Kyle M. LaPak, Xiangnan Guan
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16610c6825bd2ace4458dbaf4fa8142e
https://doi.org/10.1158/1541-7786.22511590
https://doi.org/10.1158/1541-7786.22511590
Autor:
Gregory B. Lesinski, Christin E. Burd, Trinayan Kashyap, Boris Klebanov, Marsha Crochiere, Sivan Elloul, Yosef Landesman, Kari Kendra, Gregory Young, Omar Elnaggar, Reena Shakya, Rebecca C. Hennessey, Matthew R. Farren
Selinexor, a selective inhibitor of nuclear export (SINE) compound targeting exportin-1, has previously been shown to inhibit melanoma cell growth in vivo. We hypothesized that combining selinexor with antibodies that block or disrupt T-cell checkpoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61e518810db0529b9a40a9c84db1b373
https://doi.org/10.1158/1535-7163.c.6539550
https://doi.org/10.1158/1535-7163.c.6539550
Autor:
Gregory B. Lesinski, Christin E. Burd, Trinayan Kashyap, Boris Klebanov, Marsha Crochiere, Sivan Elloul, Yosef Landesman, Kari Kendra, Gregory Young, Omar Elnaggar, Reena Shakya, Rebecca C. Hennessey, Matthew R. Farren
Supplemental Figure S1: Effects of alternative dosing schedules for selinexor (15 mg/kg) and anti-PD-1 on systemic immune populations; Supplemental Figure S2: Effects of alternative dosing schedules for selinexor (10 mg/kg) and anti-PD-1 on systemic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b62759dda4e94d4aa77a8456db24faaf
https://doi.org/10.1158/1535-7163.22510242
https://doi.org/10.1158/1535-7163.22510242
Supplemental Table 1 from Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth
Autor:
Christin E. Burd, Jianying Zhang, Reena Shakya, Christina Y. Yu, Rebecca C. Hennessey, Kyle M. LaPak, Xiangnan Guan
Real-time PCR primer sets for the analysis of SASP gene expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1372adcf31bc1e7e69a0db72c538a18f
https://doi.org/10.1158/1541-7786.22511593.v1
https://doi.org/10.1158/1541-7786.22511593.v1